INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233 | -22.6% | 7,381 | 0.0% | 0.01% | -13.3% |
| Q2 2023 | $301 | +2.4% | 7,381 | -6.3% | 0.02% | +15.4% |
| Q1 2023 | $294 | +7.3% | 7,881 | +0.3% | 0.01% | 0.0% |
| Q4 2022 | $274 | -99.9% | 7,859 | -0.2% | 0.01% | -38.1% |
| Q3 2022 | $441,000 | +8.1% | 7,872 | -0.3% | 0.02% | +16.7% |
| Q2 2022 | $408,000 | -28.9% | 7,894 | 0.0% | 0.02% | -21.7% |
| Q1 2022 | $574,000 | -38.5% | 7,894 | -0.1% | 0.02% | -20.7% |
| Q4 2021 | $933,000 | -17.4% | 7,898 | -6.1% | 0.03% | -19.4% |
| Q3 2021 | $1,129,000 | +88.8% | 8,412 | +127.7% | 0.04% | +80.0% |
| Q2 2021 | $598,000 | +564.4% | 3,694 | -42.4% | 0.02% | +900.0% |
| Q1 2017 | $90,000 | -24.4% | 6,412 | -29.4% | 0.00% | -33.3% |
| Q4 2016 | $119,000 | -25.2% | 9,077 | -2.9% | 0.00% | -40.0% |
| Q3 2016 | $159,000 | – | 9,344 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |